OSCAR HEALTH INC - CLASS A (OSCR) Stock Analyst Earnings Estimates
NYSE:OSCR - New York Stock Exchange, Inc. - US6877931096 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | ||
|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 3.964B 115.57% | 5.863B 47.92% | 9.178B 56.54% | 12.034B 31.12% | 11.311B -6.01% | 13.085B 15.68% | |
| EBITDA YoY % growth | -574.6M -8.44% | -204.921M 64.34% | 89.41M 143.63% | -40.269M -145.04% | 239.44M 694.59% | 575.27M 140.26% | |
| EBIT YoY % growth | -589.9M -8.34% | -235.615M 60.06% | 57.265M 124.30% | -101.609M -277.44% | 98.263M 196.71% | 512.45M 421.51% | |
| Operating Margin | -14.88% | -4.02% | 0.62% | -0.84% | 0.87% | 3.92% | |
| EPS YoY % growth | -2.85 13.64% | -1.20 57.89% | -0.02 98.33% | 0.70 3,619.00% | 0.90 28.36% | 1.67 85.16% |
All data in USD
| Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | |
|---|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.54 -144.93% | -0.54 12.53% | 0.69 -24.98% | 0.37 141.92% | 0.00 99.53% | -0.30 43.90% | 0.88 26.85% | 0.55 47.19% | 0.17 6,740.00% | -0.30 -0.25% |
| Revenue Q2Q % growth | 3.092B 27.59% | 2.649B 10.72% | 2.9B -4.80% | 2.809B -1.92% | 2.803B -9.35% | 2.761B 4.23% | 3.225B 11.21% | 3.275B 16.59% | 3.292B 17.45% | 3.252B 17.78% |
| EBITDA Q2Q % growth | -82.404M -223.64% | -110.89M 4.06% | 292.39M -3.77% | 160.86M 404.69% | 62.374M 175.69% | -37.783M 65.93% | 303.21M 3.70% | 204.41M 27.07% | 91.988M 47.48% | -24.825M 34.30% |
| EBIT Q2Q % growth | -115.95M -139.69% | -132.973M 9.99% | 241.86M -18.60% | 137.5M 203.12% | 42.701M 136.83% | -53.484M 59.78% | 309.22M 27.85% | 197.61M 43.72% | 93.097M 118.02% | -12.349M 76.91% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | -0.89 -545.00% | -0.47 | -0.42 | -88.51% |
| Q1 2025 Q2Q % growth | 0.92 48.39% | 0.81 | 0.11 | 13.81% |
| Q4 2024 Q2Q % growth | -0.62 6.06% | -0.60 | -0.02 | -3.02% |
| Q3 2024 Q2Q % growth | -0.22 24.14% | -0.17 | -0.05 | -25.82% |
| Q2 2024 Q2Q % growth | 0.20 385.71% | 0.16 | 0.04 | 21.28% |
| Q1 2024 Q2Q % growth | 0.62 444.44% | 0.28 | 0.34 | 123.47% |
| Q4 2023 Q2Q % growth | -0.66 37.14% | -0.74 | 0.08 | 10.44% |
| Q3 2023 Q2Q % growth | -0.29 68.13% | -0.48 | 0.19 | 39.83% |
| Q2 2023 Q2Q % growth | -0.07 86.79% | -0.23 | 0.16 | 70.16% |
| Q1 2023 Q2Q % growth | -0.18 50.00% | -0.05 | -0.13 | -247.73% |
| Q4 2022 Q2Q % growth | -1.05 -10.53% | -1.18 | 0.13 | 11.26% |
| Q3 2022 Q2Q % growth | -0.91 10.78% | -0.75 | -0.16 | -22.13% |
| Q2 2022 Q2Q % growth | -0.53 -51.43% | -0.49 | -0.04 | -8.63% |
| Q1 2022 Q2Q % growth | -0.36 63.27% | -0.22 | -0.14 | -65.31% |
| Q4 2021 Q2Q % growth | -0.95 | -0.98 | 0.03 | 3.38% |
| Q3 2021 Q2Q % growth | -1.02 | -0.67 | -0.35 | -51.69% |
| Q2 2021 Q2Q % growth | -0.35 | -0.47 | 0.12 | 26.21% |
| Q1 2021 Q2Q % growth | -0.98 | -0.54 | -0.44 | -80.07% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | 2.864B 29.05% | 2.949B | -85.05M | -2.88% |
| Q1 2025 Q2Q % growth | 3.046B 42.20% | 2.918B | 128.263M | 4.40% |
| Q4 2024 Q2Q % growth | 2.392B 67.11% | 2.524B | -131.564M | -5.21% |
| Q3 2024 Q2Q % growth | 2.423B 68.30% | 2.386B | 37.482M | 1.57% |
| Q2 2024 Q2Q % growth | 2.219B 45.86% | 2.198B | 21.341M | 0.97% |
| Q1 2024 Q2Q % growth | 2.142B 45.77% | 2.051B | 91.305M | 4.45% |
| Q4 2023 Q2Q % growth | 1.432B 43.87% | 1.449B | -17.342M | -1.20% |
| Q3 2023 Q2Q % growth | 1.44B 47.18% | 1.448B | -8.009M | -0.55% |
| Q2 2023 Q2Q % growth | 1.522B 49.57% | 1.468B | 53.535M | 3.65% |
| Q1 2023 Q2Q % growth | 1.47B 51.08% | 1.169B | 300.685M | 25.72% |
| Q4 2022 Q2Q % growth | 995.1M 100.58% | 1.106B | -110.9M | -10.03% |
| Q3 2022 Q2Q % growth | 978.4M 120.36% | 981.41M | -3.01M | -0.31% |
| Q2 2022 Q2Q % growth | 1.017B 92.20% | 973.99M | 43.31M | 4.45% |
| Q1 2022 Q2Q % growth | 972.8M 163.35% | 781.59M | 191.21M | 24.46% |
| Q4 2021 Q2Q % growth | 496.1M 214.58% | 445.23M | 50.87M | 11.43% |
| Q3 2021 Q2Q % growth | 444M 336.58% | 422.49M | 21.51M | 5.09% |
| Q2 2021 Q2Q % growth | 529.3M 359.06% | 215.14M | 314.16M | 146.03% |
| Q1 2021 Q2Q % growth | 369.4M 319.30% | 216.98M | 152.42M | 70.25% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | -224.53% | -196.18% | 0% | -5.15% |
| Revenue | -0.57% | 3.91% | 4.23% | 4.24% |